FAAH and Headache: Previous studies have shown that FAAH inhibitors that act by increasing endocannabinoid levels and extending their duration of action without eliciting the psychoactive effects related to direct CB1 receptor activation may offer a promising treatment option for headaches [21,22,25,31,34].